Bridging embryology and genetics represents a significant step forward in the evolution of assisted reproductive technologies.

At Endoscopiki SA, we believe that the future of IVF lies at the intersection of advanced embryology and precise genetic insight. As part of our commitment to introducing the latest innovations to Greece and Cyprus, our ART/IVF team recently completed intensive training at Igenomix, part of the Vitrolife Group.

The training focused on the latest protocols for advanced genetic testing, including:

• Embrace: A non-invasive embryo analysis designed to prioritize embryos for transfer without the need for biopsy.
• EndomeTRIO: A comprehensive assessment of endometrial health (ERA, EMMA, and ALICE) supporting personalized embryo transfer timing.
• PGT-A / PGT-A Plus / PGT-M / PGT-SR: Advanced screening technologies for the detection of chromosomal abnormalities and single-gene disorders.
• CGT (Carrier Genetic Test): A preconception screening tool that provides prospective parents with important genetic information.

By combining Igenomix’s genetic expertise with our long-standing experience and trusted collaboration with gynaecologists, we continue to support clinics in Greece and Cyprus in offering patients highly precise, safe, and effective pathways to parenthood.

We extend our sincere thanks to the Igenomix team, part of the Vitrolife Group, for their warm hospitality and for sharing their scientific expertise.